In this study, we found that alterations in XCL2 in cancer cells affect the prognosis of cancer patients, and that said effects may be caused by epigenetic modifications such as DNA methylation and phosphorylation that occur in cancer cells. The gene discussed is XCL2; the disease is cancer.